Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ekta Khattar

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Environmental Toxicology and Pharmacology|March 12, 2021
External environmental agents influence telomere length and telomerase activity by modulating internal cellular processes: Implications in human agingStina George Fernandes, Rebecca Dsouza, Ekta Khattar
Anti-Cancer Agents in Medicinal Chemistry|June 9, 2021
Recent Advances in Therapeutic Application of DNA Damage Response Inhibitors against CancerStina George Fernandes, Prachi Shah, Ekta Khattar
Journal of Ethnopharmacology|December 18, 2023
Mechanistic role of Syzygium cumini (L.) Skeels in glycation induced diabetic nephropathy via RAGE-NF-κB pathway and extracellular proteins modifications: A molecular approachMayura M Apte, Ekta Khattar, Rashmi S Tupe
Life Sciences|January 12, 2024
Role of p53 transcription factor in determining the efficacy of telomerase inhibitors in cancer treatmentKavita Gala, Meghna Jain, Prachi Shah, et al.
Methods (San Diego, Calif.)|January 23, 2026
Proteomics method for identifying POT1-associated complexes at telomeres using ChIP-Mass spectrometryNikita Harish Zade, Meghna Jain, Manoj Garg, et al.
Cancer Discovery|September 22, 2016
Long-Range Chromatin Interactions Drive Mutant TERT Promoter ActivationSemih Can Akıncılar, Ekta Khattar, Priscilla Li Shan Boon, et al.
Cancers|July 18, 2020
Role of Telomeres and Telomeric Proteins in Human Malignancies and Their Therapeutic PotentialStina George Fernandes, Rebecca Dsouza, Gouri Pandya, et al.
Seminars in Cancer Biology|May 8, 2020
Repurposing of drugs: An attractive pharmacological strategy for cancer therapeuticsAnuradha Kirtonia, Kavita Gala, Stina George Fernandes, et al.
Life Sciences|January 8, 2025
Anticancer and therapeutic efficacy of XPO1 inhibition in pancreatic ductal adenocarcinoma through DNA damage and modulation of miR-193b/KRAS/LAMC2/ERK/AKT signaling cascadeAnuradha Kirtonia, Gouri Pandya, Aishwarya Singh, et al.
The Journal of Clinical Investigation|April 21, 2015
Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activityCheryl M Koh, Ekta Khattar, Shi Chi Leow, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Environmental Toxicology and Pharmacology|March 12, 2021
External environmental agents influence telomere length and telomerase activity by modulating internal cellular processes: Implications in human agingStina George Fernandes, Rebecca Dsouza, Ekta Khattar
Anti-Cancer Agents in Medicinal Chemistry|June 9, 2021
Recent Advances in Therapeutic Application of DNA Damage Response Inhibitors against CancerStina George Fernandes, Prachi Shah, Ekta Khattar
Journal of Ethnopharmacology|December 18, 2023
Mechanistic role of Syzygium cumini (L.) Skeels in glycation induced diabetic nephropathy via RAGE-NF-κB pathway and extracellular proteins modifications: A molecular approachMayura M Apte, Ekta Khattar, Rashmi S Tupe
Life Sciences|January 12, 2024
Role of p53 transcription factor in determining the efficacy of telomerase inhibitors in cancer treatmentKavita Gala, Meghna Jain, Prachi Shah, et al.
Methods (San Diego, Calif.)|January 23, 2026
Proteomics method for identifying POT1-associated complexes at telomeres using ChIP-Mass spectrometryNikita Harish Zade, Meghna Jain, Manoj Garg, et al.
Cancer Discovery|September 22, 2016
Long-Range Chromatin Interactions Drive Mutant TERT Promoter ActivationSemih Can Akıncılar, Ekta Khattar, Priscilla Li Shan Boon, et al.
Cancers|July 18, 2020
Role of Telomeres and Telomeric Proteins in Human Malignancies and Their Therapeutic PotentialStina George Fernandes, Rebecca Dsouza, Gouri Pandya, et al.
Seminars in Cancer Biology|May 8, 2020
Repurposing of drugs: An attractive pharmacological strategy for cancer therapeuticsAnuradha Kirtonia, Kavita Gala, Stina George Fernandes, et al.
Life Sciences|January 8, 2025
Anticancer and therapeutic efficacy of XPO1 inhibition in pancreatic ductal adenocarcinoma through DNA damage and modulation of miR-193b/KRAS/LAMC2/ERK/AKT signaling cascadeAnuradha Kirtonia, Gouri Pandya, Aishwarya Singh, et al.
The Journal of Clinical Investigation|April 21, 2015
Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activityCheryl M Koh, Ekta Khattar, Shi Chi Leow, et al.
Pageof 3